NCT02183792View on ClinicalTrials.gov

Aquaresis Utility for Hyponatremic Acute Heart Failure Study

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

March 31, 2018

Conditions
Heart Failure
Interventions
DRUG

Tolvaptan

DRUG

Furosemide

Trial Locations (2)

90033

Keck Medical Center of USC, Los Angeles

LAC+USC Medical Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

University of Southern California

OTHER